|
H2AC11 expression profile based on
|
BRCA : Breast invasive carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.50961420617281E-25
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.89651947993793E-06 |
| Normal-vs-Stage2 |
2.25355944838844E-19 |
| Normal-vs-Stage3 |
2.55612573753447E-12 |
| Normal-vs-Stage4 |
1.784615E-03 |
| Stage1-vs-Stage2 |
1.112202E-02 |
| Stage1-vs-Stage3 |
6.014463E-03 |
| Stage1-vs-Stage4 |
8.921083E-02 |
| Stage2-vs-Stage3 |
4.260053E-01 |
| Stage2-vs-Stage4 |
4.588850E-01 |
| Stage3-vs-Stage4 |
7.220946E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.87668018226767E-20 |
| Normal-vs-AfricanAmerican |
5.23219972802005E-12 |
| Normal-vs-Asian |
4.473563E-04 |
| Caucasian-vs-AfricanAmerican |
3.412036E-01 |
| Caucasian-vs-Asian |
1.961540E-02 |
| AfricanAmerican-vs-Asian |
3.420563E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.303242E-03 |
| Normal-vs-Female |
4.22464608473205E-25 |
| Male-vs-Female |
2.608006E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.5435064273787E-07 |
| Normal-vs-Age(41-60Yrs) |
6.09059815664913E-17 |
| Normal-vs-Age(61-80Yrs) |
2.16558586964503E-14 |
| Normal-vs-Age(81-100Yrs) |
1.688337E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.833353E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.216413E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.585360E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.957378E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.756866E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.262512E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Pre-menopause |
2.05394827590801E-09 |
| Normal-vs-Peri-menopause |
3.195585E-03 |
| Normal-vs-Post-menopause |
5.98167873121286E-20 |
| Pre-menopause-vs-Peri-menopause |
9.096283E-01 |
| Pre-menopause-vs-Post-menopause |
2.982785E-02 |
| Peri-menopause-vs-Post-menopause |
2.391546E-01 |
|
|
| Subtype descriptions |
| IDC | Infiltrating Ductal Carcinoma |
ILC | Infiltrating Lobular Carcinoma |
| Mixed | Mixed histology |
Mucinous | Mucinous Carcinoma |
| Medullary | Medullary Carcinoma |
Metaplastic | Metaplastic Carcinoma |
| INOS | Infiltrating Carcinoma NOS |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-IDC |
1.877472E-02 |
| Normal-vs-ILC |
3.13798654131234E-26 |
| Normal-vs-Mixed |
1.946276E-02 |
| Normal-vs-Other |
4.676023E-03 |
| Normal-vs-Mucinous |
5.604312E-02 |
| Normal-vs-Metaplastic |
1.676177E-01 |
| Normal-vs-INOS |
NA |
| Normal-vs-Medullary |
6.683278E-04 |
| IDC-vs-ILC/td>
| 5.06669273654614E-18 |
| IDC-vs-Mixed |
6.438934E-02 |
| IDC-vs-Other |
8.169957E-03 |
| IDC-vs-Mucinous |
1.160596E-01 |
| IDC-vs-Metaplastic |
2.136498E-01 |
| IDC-vs-INOS |
NA |
| IDC-vs-Medullary |
5.912559E-03 |
| ILC-vs-Mixed |
5.904687E-01 |
| ILC-vs-Other |
8.824321E-02 |
| ILC-vs-Mucinous |
5.410499E-01 |
| ILC-vs-Metaplastic |
5.661254E-01 |
| ILC-vs-Mixed |
NA |
| ILC-vs-INOS |
6.273468E-01 |
| ILC-vs-Medullary |
7.183237E-02 |
| Mixed-vs-Other |
9.473686E-01 |
| Mixed-vs-Mucinous |
4.803891E-01 |
| Mixed-vs-Metaplastic |
NA |
| Mixed-vs-INOS |
8.794849E-01 |
| Mixed-vs-Medullary |
6.686064E-02 |
| Other-vs-Mucinous |
6.513020E-01 |
| Other-vs-Metaplastic |
NA |
| Other-vs-INOS |
7.333157E-02 |
| Other-vs-Medullary |
4.643261E-01 |
| Mucinous-vs-Metaplastic |
NA |
| Mucinous-vs-INOS |
8.205620E-01 |
| Mucinous-vs-Medullary |
NA |
| Metaplastic-vs-INOS |
5.054425E-01 |
| Metaplastic-vs-Medullary |
NA |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Luminal |
1.06334645871636E-15 |
| Normal-vs-HER2Positive |
4.00492232487407E-05 |
| Normal-vs-TNBC |
2.07795299066989E-07 |
| Luminal-vs-HER2Positive |
4.215365E-01 |
| Luminal-vs-TNBC |
7.087958E-01 |
| HER2Positive-vs-TNBC |
6.494214E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-TP53 mutant |
2.38953541606447E-19 |
| Normal-vs-TP53 nonmutant |
2.32088964373691E-15 |
| TP53 mutant-vs-TP53 nonmutant |
1.009688E-03 |
|
|
| Subtype descriptions |
| TNBC-BL1 | TNBC-Basal like 1 |
TNBC-BL2 | TNBC-Basal like 2 |
| TNBC-LAR | TNBC-luminal androgen receptor |
TNBC-IM | TNBC-immunomodulatory |
| TNBC-MSL | TNBC-mesenchymal stem–like |
TNBC-M | TNBC-mesenchymal |
| TNBC-UNS | TNBC-unspecified |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Luminal |
1.06334645871636E-15 |
| Normal-vs-HER2positive |
4.00492232487407E-05 |
| Normal-vs-TNBC-BL1 |
2.087423E-02 |
| Normal-vs-TNBC-BL2 |
1.221933E-02 |
| Normal-vs-TNBC-LAR |
8.141063E-02 |
| Normal-vs-TNBC-IM |
3.506467E-02 |
| Normal-vs-TNBC-M |
1.296671E-02 |
| Normal-vs-TNBC-MSL |
2.996289E-01 |
| Normal-vs-TNBC-UNS |
1.120421E-01 |
| Luminal-vs-HER2positive |
4.215365E-01 |
| Luminal-vs-TNBC-BL1 |
3.019201E-01 |
| Luminal-vs-TNBC-BL2 |
9.173915E-01 |
| Luminal-vs-TNBC-LAR |
4.630726E-01 |
| Luminal-vs-TNBC-IM |
8.171338E-01 |
| Luminal-vs-TNBC-M |
7.249725E-01 |
| Luminal-vs-TNBC-MSL |
5.816925E-01 |
| Luminal-vs-TNBC-UNS |
9.496933E-01 |
| HER2Positive-vs-TNBC-BL1 |
5.048949E-01 |
| HER2Positive-vs-TNBC-BL2 |
6.515767E-01 |
| HER2Positive-vs-TNBC-LAR |
6.472267E-01 |
| HER2Positive-vs-TNBC-IM |
4.998713E-01 |
| HER2Positive-vs-TNBC-M |
8.928420E-01 |
| HER2Positive-vs-TNBC-MSL |
3.944364E-01 |
| HER2Positive-vs-TNBC-UNS |
7.857071E-01 |
| TNBC-BL1-vs-TNBC-BL2 |
3.691759E-01 |
| TNBC-BL1-vs-TNBC-LAR |
9.455551E-01 |
| TNBC-BL1-vs-TNBC-IM |
3.034167E-01 |
| TNBC-BL1-vs-TNBC-M |
4.920378E-01 |
| TNBC-BL1-vs-TNBC-MSL |
2.410836E-01 |
| TNBC-BL1-vs-TNBC-UNS |
4.686685E-01 |
| TNBC-BL2-vs-TNBC-LAR |
5.117237E-01 |
| TNBC-BL2-vs-TNBC-IM |
7.984583E-01 |
| TNBC-BL2-vs-TNBC-M |
8.230462E-01 |
| TNBC-BL2-vs-TNBC-MSL |
5.791897E-01 |
| TNBC-BL2-vs-TNBC-UNS |
9.951760E-01 |
| TNBC-LAR-vs-TNBC-IM |
4.369953E-01 |
| TNBC-LAR-vs-TNBC-M |
6.172633E-01 |
| TNBC-LAR-vs-TNBC-MSL |
3.431434E-01 |
| TNBC-LAR-vs-TNBC-UNS |
5.726463E-01 |
| TNBC-IM-vs-TNBC-M |
6.670438E-01 |
| TNBC-IM-vs-TNBC-MSL |
7.313126E-01 |
| TNBC-IM-vs-TNBC-UNS |
8.552070E-01 |
| TNBC-M-vs-TNBC-MSL |
4.963647E-01 |
| TNBC-M-vs-TNBC-UNS |
8.779634E-01 |
| TNBC-MSL-vs-TNBC-UNS |
6.572116E-01 |
|
|
